copper tripeptide-34 hcl은 임신 중 안전한가요?
No harmonised reproductive classification in ECHA Annex VI, no SCCS or CIR safety opinion flagging reproductive risk, and no peer‑reviewed evidence showing teratogenicity for topical copper peptide preparations. Topical copper peptides generally give low systemic exposure (negligible to low absorption reported for copper-containing cosmetic complexes). Sources: ECHA Annex VI (no harmonised CLP for copper tripeptide), CIR (no reproductive safety restriction for cosmetic copper peptides), PubMed (no reproductive/teratology studies for copper tripeptide complexes).
Related ingredients
Frequently asked questions
- copper tripeptide-34 hcl은 임신 중 안전한가요?
- No harmonised reproductive classification in ECHA Annex VI, no SCCS or CIR safety opinion flagging reproductive risk, and no peer‑reviewed evidence showing teratogenicity for topical copper peptide preparations. Topical copper peptides generally give low systemic exposure (negligible to low absorption reported for copper-containing cosmetic complexes). Sources: ECHA Annex VI (no harmonised CLP for copper tripeptide), CIR (no reproductive safety restriction for cosmetic copper peptides), PubMed (no reproductive/teratology studies for copper tripeptide complexes).
- copper tripeptide-34 hcl은 모유 수유 중 안전한가요?
- Same rationale as pregnancy: no regulatory harmonised reproductive hazard or authoritative safety opinions indicating risk; topical use gives low systemic absorption so breastmilk exposure expected to be low. No peer‑reviewed data showing transfer into breastmilk for cosmetic copper peptides. Sources: ECHA Annex VI, CIR, PubMed.
- copper tripeptide-34 hcl은 아기 피부에 안전한가요?
- No evidence of intrinsic reproductive or developmental toxicity for copper tripeptide complexes. However, infant skin has a more permeable barrier and higher surface‑area‑to‑weight ratio; therefore exposure potential is increased compared with adults. If adult topical exposure is low (e=1), infant exposure is conservatively increased by +1. Sources: general dermal absorption principles, absence of harmonised CLP/SCCS/CIR concerns, PubMed (no infant-specific toxicity data).
- VeriMom은 copper tripeptide-34 hcl을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 copper tripeptide-34 hcl을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 copper tripeptide-34 hcl 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.